Long-Term Follow-Up of Women in Trials of Adjuvant Therapy for Breast Cancer: Is It Still Important?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 1, 2011
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Drug Administration Schedule (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Humans (MeSH)
- Middle Aged (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Randomized Controlled Trials as Topic (MeSH)
- Tamoxifen (MeSH)
published in
- Journal of Clinical Oncology Journal